Process

Details for Australian Patent Application No. 2004291709 (hide)

Owner AstraZeneca UK Limited The University of Tokyo

Inventors Sone, Saburo; Tsuruo, Takashi; Fukuoka, Masahiro; Nakamura, Yusuke

Agent FB Rice

Pub. Number AU-B-2004291709

PCT Pub. Number WO2005/049829

Priority 0322636.2 26.09.03 GB; 0327132.7 21.11.03 GB; 0312451.8 30.05.03 GB

Filing date 1 June 2004

Wipo publication date 2 June 2005

Acceptance publication date 10 September 2009

International Classifications

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

1 December 2005 PCT application entered the National Phase

  PCT publication WO2005/049829 Priority application(s): WO2005/049829

10 September 2009 Application Accepted

  Published as AU-B-2004291709

19 November 2009 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 29 Oct 2009. Address for service in Australia - FB Rice & Co Level 23 44 Market Street Sydney NSW 2000 2005

11 March 2010 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 29 Oct 2009 2005

18 March 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004291715-Gene

2004291708-Method for production of a block of concrete and reinforcing cage for a block produced thus